Meeting
2019 Gastrointestinal Cancers Symposium
MAPK pathway proteins expression and correlation with clinicopathological indices and long-term outcome according to the etiology of underlying chronic liver disease in hepatocellular carcinoma.
Authors
Paulo Henrique Costa Diniz
Federal University of Minas Gerais, Belo Horizonte, Brazil
Paulo Henrique Costa Diniz , Serena Dafne do Carmo Silva , Caio Cesar Lobo Sampaio , Paula Vieira Teixeira Vidigal , Marcelo Antonio Pascoal Xavier , Luciana Costa Faria , Teresa Cristina de Abreu Ferrari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 286)
DOI
10.1200/JCO.2019.37.4_suppl.286
Abstract #
286
Poster Bd #
F4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis.
First Author: Matthew Dankner
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2021 ASCO Annual Meeting
Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer.
First Author: Justin Wayne Wong Tiu-lim
Poster
2020 ASCO Virtual Scientific Program
The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.
First Author: Matthew K Stein